We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » CMS' Rationale for Compounded Drug Reimbursement Rates Looms Large
CMS' Rationale for Compounded Drug Reimbursement Rates Looms Large
October 18, 2006
Observers on all sides of the dispute over Medicare coverage of certain compounded drugs are anxiously awaiting the Centers for Medicare & Medicaid Services' (CMS) decision about what factors will be considered in setting reimbursement rates.